Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C18H18ClN3O |
| Molecular Weight | 327.808 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)(O)C1=CC=CN2C1=NN=C2C3(CC3)C4=CC=C(Cl)C=C4
InChI
InChIKey=PTIFVLOBVCIMKL-UHFFFAOYSA-N
InChI=1S/C18H18ClN3O/c1-17(2,23)14-4-3-11-22-15(14)20-21-16(22)18(9-10-18)12-5-7-13(19)8-6-12/h3-8,11,23H,9-10H2,1-2H3
| Molecular Formula | C18H18ClN3O |
| Molecular Weight | 327.808 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: P28845 Gene ID: 3290.0 Gene Symbol: HSD11B1 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/27169762 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 21:01:54 GMT 2025
by
admin
on
Mon Mar 31 21:01:54 GMT 2025
|
| Record UNII |
8JYO8VTR11
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
42634627
Created by
admin on Mon Mar 31 21:01:54 GMT 2025 , Edited by admin on Mon Mar 31 21:01:54 GMT 2025
|
PRIMARY | |||
|
1140897-32-0
Created by
admin on Mon Mar 31 21:01:54 GMT 2025 , Edited by admin on Mon Mar 31 21:01:54 GMT 2025
|
PRIMARY | |||
|
8JYO8VTR11
Created by
admin on Mon Mar 31 21:01:54 GMT 2025 , Edited by admin on Mon Mar 31 21:01:54 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
METABOLIC ENZYME -> SUBSTRATE |
MAJOR
|
||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
METABOLIC ENZYME -> SUBSTRATE |
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| Biological Half-life | PHARMACOKINETIC |
|
SINGLE DOSE ADMINISTRATION |
|
||
| Tmax | PHARMACOKINETIC |
|
IN HEALTHY CHINESE SUBJECTS |
|
||